Endovascular Occlusion of a Renal Arteriovenous Fistula with Renal Vein Aneurysm Formation for Rupture Prevention.

Case Reports in Vascular Medicine Pub Date : 2019-10-31 eCollection Date: 2019-01-01 DOI:10.1155/2019/8530641
Yae Hyun Rhee, Lucas Busch, Roberto Sansone, Neslihan Ertas, Nikolaos Floros, Hubert Schelzig, Joscha Mulorz, Markus Udo Wagenhäuser
{"title":"Endovascular Occlusion of a Renal Arteriovenous Fistula with Renal Vein Aneurysm Formation for Rupture Prevention.","authors":"Yae Hyun Rhee,&nbsp;Lucas Busch,&nbsp;Roberto Sansone,&nbsp;Neslihan Ertas,&nbsp;Nikolaos Floros,&nbsp;Hubert Schelzig,&nbsp;Joscha Mulorz,&nbsp;Markus Udo Wagenhäuser","doi":"10.1155/2019/8530641","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To report the effectiveness of left renal artery (LRA) occlusion using Amplatzer Vascular Plug (AVP) II as treatment for a high-flow renal arteriovenous fistula (RAVF) with multiple renal vein aneurysms (RVA) to prevent aneurysm rupture and cardiac decompensation.</p><p><strong>Case report: </strong>A 59-year-old female suffering from a post-traumatic RAVF presented with tachycardia and increased cardiac output (CO). Doppler ultrasonography and computed tomography (CT) scan revealed a high-flow RAVF with multiple RVAs and unilateral critically reduced kidney function. Appreciating recent interventional therapeutic advances, the patient was treated with endovascular placement of AVP II into the left renal artery (LRA) resulting in complete occlusion of the RAVF to effectively reduce the risk of RVA rupture and cardiac decompensation. No anti-platelet medication was administrated after the occlusion of the LRA. The patient's physical capacity improved since right heart volume strain was normalized, and CO was reduced.</p><p><strong>Conclusion: </strong>Transbrachial AVP II occlusion of the LRA is effective to occlude high-flow RAVFs to prevent risk of life-threatening RVA rupture. Additional follow-up is warranted to verify long-term effectiveness of this approach.</p>","PeriodicalId":9632,"journal":{"name":"Case Reports in Vascular Medicine","volume":"2019 ","pages":"8530641"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/8530641","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Vascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/8530641","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Purpose: To report the effectiveness of left renal artery (LRA) occlusion using Amplatzer Vascular Plug (AVP) II as treatment for a high-flow renal arteriovenous fistula (RAVF) with multiple renal vein aneurysms (RVA) to prevent aneurysm rupture and cardiac decompensation.

Case report: A 59-year-old female suffering from a post-traumatic RAVF presented with tachycardia and increased cardiac output (CO). Doppler ultrasonography and computed tomography (CT) scan revealed a high-flow RAVF with multiple RVAs and unilateral critically reduced kidney function. Appreciating recent interventional therapeutic advances, the patient was treated with endovascular placement of AVP II into the left renal artery (LRA) resulting in complete occlusion of the RAVF to effectively reduce the risk of RVA rupture and cardiac decompensation. No anti-platelet medication was administrated after the occlusion of the LRA. The patient's physical capacity improved since right heart volume strain was normalized, and CO was reduced.

Conclusion: Transbrachial AVP II occlusion of the LRA is effective to occlude high-flow RAVFs to prevent risk of life-threatening RVA rupture. Additional follow-up is warranted to verify long-term effectiveness of this approach.

Abstract Image

Abstract Image

Abstract Image

血管内封堵肾动静脉瘘并发肾静脉动脉瘤预防破裂。
目的:报道Amplatzer血管塞(AVP) II闭塞左肾动脉(LRA)治疗合并多肾静脉动脉瘤(RVA)的高流量肾动静脉瘘(RAVF)的疗效,以防止动脉瘤破裂和心脏失代偿。病例报告:一名59岁女性,患有创伤后RAVF,表现为心动过速和心输出量(CO)增加。多普勒超声和计算机断层扫描(CT)显示高流量RAVF伴多个RVAs和单侧肾功能严重下降。鉴于近期介入治疗的进展,患者接受血管内植入AVP II至左肾动脉(LRA),使RAVF完全闭塞,以有效降低RVA破裂和心脏失代偿的风险。LRA闭塞后未给予抗血小板药物治疗。右心容积应变正常化后,患者体能得到改善,CO降低。结论:经肱AVPⅱ阻断LRA可有效阻断高流量ravf,防止危及生命的RVA破裂风险。需要进一步的后续行动来验证这种方法的长期有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
21
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信